Trials / Unknown
UnknownNCT04766281
MLC901 in Moderate Traumatic Brain Injury
Safety and Efficacy of MLC901 (NeuroAiD Ii) in Patients With Moderate TBI: A Randomized Double Blind Placebo Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of the Philippines · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study wants to evaluate whether MLC901 will help improve the condition of adult patients with moderate traumatic brain injury.
Detailed description
This is a double blind placebo controlled randomized trial to determine whether giving MLC901 for 6 months will improve the outcomes in a adult patients with moderate traumatic brain injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MLC901 | This consists of extracts from 9 herbal components in a dark blue/light blue capsule |
| GENETIC | Placebo | This consists of a dark brown powder in size 0 dark blue/light blue vegetable capsule |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2024-05-30
- Completion
- 2024-07-31
- First posted
- 2021-02-23
- Last updated
- 2023-06-13
Locations
3 sites across 1 country: Philippines
Source: ClinicalTrials.gov record NCT04766281. Inclusion in this directory is not an endorsement.